VERICEL CORPORATION Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
VERICEL CORPORATION (VCEL) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$197.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-07-30
- VERICEL CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$197.00K, a 519.15% decline year-over-year.
- VERICEL CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$443.00K, a 435.61% decline year-over-year.
- VERICEL CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $75.00K, a 88.13% decline year-over-year.
- VERICEL CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was $47.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month |
|---|---|---|---|
| 2026-06-30 | -$197.00K 10-Q · filed 2026-07-30 | -$640.00K 10-Q · filed 2026-07-30 | |
| 2026-03-31 | -$443.00K 10-Q · filed 2026-07-30 | ||
| 2025-09-30 | $75.00K 10-Q · filed 2025-11-06 | $122.00K derived: sum of 2 quarters · filed 2026-07-30 | $254.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $47.00K 10-Q · filed 2026-07-30 | $179.00K 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $132.00K 10-Q · filed 2026-07-30 | ||
| 2024-09-30 | $632.00K 10-Q · filed 2025-11-06 | $604.00K derived: sum of 2 quarters · filed 2025-11-06 | $459.00K 10-Q · filed 2025-11-06 |
| 2024-06-30 | -$28.00K 10-Q · filed 2025-11-06 | -$173.00K 10-Q · filed 2025-07-31 | |
| 2024-03-31 | -$145.00K 10-Q · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |